Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Biel, John H.
1967.
Vol. 2,
Issue. ,
p.
11.
Burke, B. V.
Sainsbury, M. J.
and
Mezo, B. A.
1967.
A COMPARATIVE TRIAL OF AMITRIPTYLINE AND TRIMIPRAMINE IN THE TREATMENT OF DEPRESSION.
Medical Journal of Australia,
Vol. 1,
Issue. 24,
p.
1216.
WINSLOW, WALTER W.
STONE, WALTER N.
and
HOFLING, CHARLES K.
1967.
Progress in Neurology and Psychiatry.
p.
509.
Takahashi, Ryo
Nagao, Yoshiko
Tsuchiya, Kenji
Takamizawa, Misa
Kobayashi, Teruyoshi
Toru, Michio
Kobayashi, Kenichi
and
Kariya, Tetsuhiko
1968.
Catecholamine metabolism of manic-depressive illness.
Journal of Psychiatric Research,
Vol. 6,
Issue. 3,
p.
185.
RICKELS, KARL
BAZILIAN, STANFORD E.
GORDON, PAUL E.
WEISE, CHARLES C.
FELDMAN, HAROLD S.
and
WILSON, DANIEL A.
1970.
Amitriptyline and Trimipramine in Neurotic Depressed Outpatients: A Collaborative Study.
American Journal of Psychiatry,
Vol. 127,
Issue. 2,
p.
208.
HUSSAIN, M. Z.
and
CHAUDHRY, Z. A.
1973.
Single Versus Divided Daily Dose of Trimipramine in the Treatment of Depressive Illness.
American Journal of Psychiatry,
Vol. 130,
Issue. 10,
p.
1142.
BIEL, JOHN H.
and
BOPP, BARBARA
1974.
Psychopharmacological Agents.
p.
283.
Warot, D.
Molinier, P.
Lacomblez, L.
Payan, C.
Danjou, Ph.
and
Puech, A. J.
1989.
Dose related effects of trimipramine on psychomotor function, memory, and autonomic nervous system activity in healthy volunteers.
Human Psychopharmacology: Clinical and Experimental,
Vol. 4,
Issue. 2,
p.
121.
Laux, G.
Delini-Stula, A.
Breyer-Pfaff, U.
Rickels, K.
Osterheider, M.
Sieberns, S.
Heininger, K.
Becker, T.
Dietmaier, O.
and
Wendt, G.
1993.
Neuro-Psychopharmaka.
p.
355.
Laux, G.
Breyer-Pfaff, U.
Broich, K.
Delini-Stula, A.
and
Steiger, A.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
559.
Fangmann, Peter
Assion, Hans-Jörg
Juckel, Georg
González, Cecilio Álamo
and
López-Muñoz, Francisco
2008.
Half a Century of Antidepressant Drugs.
Journal of Clinical Psychopharmacology,
Vol. 28,
Issue. 1,
p.
1.
Lipponen, Anssi
El-Osta, Assam
Kaspi, Antony
Ziemann, Mark
Khurana, Ishant
KN, Harikrishnan
Navarro-Ferrandis, Vicente
Puhakka, Noora
Paananen, Jussi
and
Pitkänen, Asla
2018.
Transcription factors Tp73, Cebpd, Pax6, and Spi1 rather than DNA methylation regulate chronic transcriptomics changes after experimental traumatic brain injury.
Acta Neuropathologica Communications,
Vol. 6,
Issue. 1,
Lipponen, Anssi
Natunen, Teemu
Hujo, Mika
Ciszek, Robert
Hämäläinen, Elina
Tohka, Jussi
Hiltunen, Mikko
Paananen, Jussi
Poulsen, David
Kansanen, Emilia
Ekolle Ndode-Ekane, Xavier
Levonen, Anna-Liisa
and
Pitkänen, Asla
2019.
In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury—Lessons Learned.
International Journal of Molecular Sciences,
Vol. 20,
Issue. 21,
p.
5395.
Pitsillou, Eleni
Bresnehan, Sarah M.
Kagarakis, Evan A.
Wijoyo, Stevano J.
Liang, Julia
Hung, Andrew
and
Karagiannis, Tom C.
2020.
The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.
Molecular Biology Reports,
Vol. 47,
Issue. 1,
p.
753.
eLetters
No eLetters have been published for this article.